Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 117th Congress · H.R. 6000 (Introduced in House) — To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes. · Sec. 2

Sec. 2. Table of contents

360 words·~2 min read·/bill/117/hr/6000/ih/section-2·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

The table of contents of this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. Title I—Public health Sec. 101. Further understanding the implications of long COVID. Sec. 102. National strategy to prevent and respond to pandemics. Sec. 103. Pandemic preparedness rare disease support program. Sec. 104. Vaccine and immunization programs. Sec. 105. Developing antimicrobial innovations. Title II—Patients and caregivers Sec. 201. Educational programs and training for caregivers.
Sec. 202. Increasing health literacy to promote better outcomes for patients. Sec. 203. Increasing diversity in clinical trials. Sec. 204. Patient experience data. Sec. 205. Ensuring coverage for clinical trials under existing standard of care. Title III—Food and Drug Administration Sec. 301. Report on collaboration and alignment in regulating digital health technologies. Sec. 302. Grants for novel trial designs and other innovations in drug development. Sec. 303. FDA cell and gene therapy.
Sec. 304. Increasing use of real world evidence. Sec. 305. Improving FDA–CMS communication regarding transformative new therapies. Sec. 306. Establishment of additional Intercenter Institutes at the Food and Drug Administration. Sec. 307. Accelerating timeline for breakthrough and RMAT designations. Sec. 308. Guidance regarding development and submission of chemistry, manufacturing, and controls information for expedited approval. Sec. 309. Post-approval study requirements for accelerated approval.
Sec. 310. Recommendations to decentralize clinical trials. Title IV—Centers for Medicare & Medicaid Services Sec. 401. GAO study and report. Sec. 402. Strategies to increase access to telehealth under Medicaid and Children’s Health Insurance Program. Sec. 403. Extending Medicare telehealth flexibilities. Sec. 404. Coverage and payment for breakthrough devices under the Medicare program. Sec. 405. Secretary of Health and Human Services report on coverage for innovative technologies.
Sec. 406. Secretary of Health and Human Services report on CMS computer systems. Sec. 407. Precision Medicine Answers for Kids Today. Sec. 408. Medicare coverage for consultations. Sec. 409. Prohibiting the use of geographic tracking features and biometrics within Medicaid electronic visit verification systems. Sec. 410. Generally accepted standard for electronic prescribing. Sec. 411. Meaningful access to Federal health plan claims data. Title V—Research Sec. 501. Advanced Research Projects Agency for Health.
Sec. 502. Research investment to spark the economy. Sec. 503. Research Policy Board reauthorization.
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.